Aileron raises $40M

Drug developer focuses on treatments for cancer, and immune, metabolic and infectious diseases.

15 June 2009•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.